Presentations

Documents

Order by : Name | Date | Hits | [ Ascendant ]

A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells... A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.52 MB
Downloads: 717

"A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells predicts the power of HSC-specific TGFβ pathway inhibition"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Altered lipid metabolism in obesity, nonalcoholic fatty liver disease and the associated... Altered lipid metabolism in obesity, nonalcoholic fatty liver disease and the associated...

hot!
Date added: 06/28/2019
Date modified: 06/28/2019
Filesize: 256 Bytes
Downloads: 716

"Altered lipid metabolism in obesity, non-alcoholic fatty liver disease and the associated co-morbidities"

Oral presentation given by ORU at the 2nd International Symposium on Lipid Science and Health, Qingdao, China, 4th November 2018

Hepatocellular carcinoma and metabolic risk factors in a main reference centre in Italy Hepatocellular carcinoma and metabolic risk factors in a main reference centre in Italy

hot!
Date added: 01/04/2018
Date modified: 01/04/2018
Filesize: 788.84 kB
Downloads: 710

Poster presentation given by UNITO at the 50th Annual Meeting of the Italian Association for the Study of the Liver (AISF), Rome, Italy, 23rd - 24th February 2017

Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a... Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.91 MB
Downloads: 710

"Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a model of non-alcoholic fatty liver disease (NAFLD)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Lipopolysaccharide increases the release of CXCL5 in an ex-vivo model for human non-alcoholic... Lipopolysaccharide increases the release of CXCL5 in an ex-vivo model for human non-alcoholic...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.59 MB
Downloads: 710

"Lipopolysaccharide increases the release of CXCL5 in an ex-vivo model for human non-alcoholic fatty liver disease"

Poster presentation given by UNEW at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Collagens of the Liver: a large family with diverse functions Collagens of the Liver: a large family with diverse functions

hot!
Date added: 06/30/2019
Date modified: 06/30/2019
Filesize: 256 Bytes
Downloads: 703

Oral presentation given by UMC at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

Mechanisms of Fibrogenesis in NASH Mechanisms of Fibrogenesis in NASH

hot!
Date added: 06/28/2019
Date modified: 06/28/2019
Filesize: 256 Bytes
Downloads: 687

Oral presentation given by UNEW at the EASL NAFLD Summit, Geneva, Switzerland, 21st September 2018

Severity of NAFLD/NASH is associated with both more severe β-cell dysfunction and reduced insulin... Severity of NAFLD/NASH is associated with both more severe β-cell dysfunction and reduced insulin...

hot!
Date added: 06/30/2019
Date modified: 06/30/2019
Filesize: 256 Bytes
Downloads: 683

"Severity of NAFLD/NASH is associated with both more severe β-cell dysfunction and reduced insulin clearance independently of body weight in a large cohort of nondiabetic subjects: further insights in the causative role of NASH in T2DM development"

Oral presentation given by CNR at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

Clinical Events: Liver-Related Outcomes Clinical Events: Liver-Related Outcomes

hot!
Date added: 06/28/2019
Date modified: 06/28/2019
Filesize: 256 Bytes
Downloads: 676

Oral presentation given by UNEW at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

The EPoS staging system is a reproducible 7-tier fibrosis score for NAFLD adapted both to glass... The EPoS staging system is a reproducible 7-tier fibrosis score for NAFLD adapted both to glass...

hot!
Date added: 01/19/2019
Date modified: 01/19/2019
Filesize: 958.42 kB
Downloads: 668

"The EPoS staging system is a reproducible 7-tier fibrosis score for NAFLD adapted both to glass slides and digitized images (e-slides)"

Poster presentation given by UNEW, APHP & UHEL at the EASL International Liver Congress, Paris, France, 11th - 15th April 2018